OptimizeRx Corp OPRX
OptimizeRx is a leading digital healthcare technology company that is redefining how life sciences brands engage with, market their services and products to, and support patients and healthcare providers. We leverage our proprietary technology solutions and partnerships to help our clients develop and execute highly individualized and targeted marketing campaigns to drive physician and patient engagement and to enhance patient care. OptimizeRx is a Nevada corporation and was founded in 2006 in Rochester, Michigan, as a healthcare technology company delivering various types of messages to target audiences, including coupons and co-pays directly to physicians and pharmacists through electronic health record ("EHR") systems and ePrescribing ("eRx") platforms. Over time, the demand for different types of communication and marketing solutions among life sciences organizations, healthcare professionals ("HCPs"), and patients led us to expand upon our initial solution to increase the variety of health-related information we deliver, as well as the platforms, technology, and audiences through, and to which we deliver.
Valuation FY2025 figures against the last close
Annual financial statements
Income statement
| Fiscal year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $109.4M | $92.1M | $71.5M | $62.5M | $4.5M | $43.3M | $24.6M | $21.2M | $12.1M | $7.8M |
| Cost of revenue | $35.8M | $32.7M | $28.6M | $23.5M | $25.7M | $19.2M | $9.2M | $9.0M | — | — |
| Gross profit | $73.6M | $59.4M | $42.9M | $39.0M | $35.6M | $24.1M | $15.4M | $12.2M | $6.0M | $4.3M |
| R&D | $0 | $0 | — | — | — | $0 | $1.6M | $0 | — | — |
| SG&A | — | — | — | $33.5M | $27.7M | — | — | — | — | — |
| Total operating expenses | $61.9M | $73.1M | $69.3M | $51.3M | $35.3M | $26.2M | $19.1M | $12.0M | $8.1M | $5.9M |
| Operating income | $11.7M | -$13.7M | -$26.4M | -$12.3M | $361.1K | -$2.1M | -$3.7M | $180.1K | -$2.1M | -$1.6M |
| Interest expense | $5.3M | $6.2M | $1.5M | — | — | — | — | — | — | — |
| Pre-tax income | $7.0M | -$19.4M | -$25.2M | -$11.4M | $378.1K | -$2.2M | -$4.0M | $226.3K | -$2.1M | -$1.5M |
| Income tax | $1.8M | $725.0K | $7.6M | — | — | — | $898.0K | — | — | — |
| Net income | $5.1M | -$20.1M | -$17.6M | -$11.4M | $378.1K | -$2.2M | -$3.1M | $226.3K | -$2.1M | -$1.5M |
| EPS, basic | 0.28 | -1.10 | -1.03 | -0.64 | 0.02 | -0.15 | -0.23 | 0.02 | -0.21 | -0.05 |
| EPS, diluted | 0.27 | -1.10 | -1.03 | -0.64 | 0.02 | -0.15 | -0.23 | 0.02 | -0.21 | -0.05 |
| Shares, diluted (wtd. avg.) | 19.0M | 18.3M | 17.1M | 17.8M | 17.7M | 14.8M | 13.4M | 11.9M | 9.8M | 29.7M |
Balance sheet
| Fiscal year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | $23.4M | $13.4M | $13.9M | $18.2M | $84.7M | $10.5M | $18.9M | $8.9M | $5.1M | $7.0M |
| Short-term investments | $0 | $0 | — | $55.9M | — | — | — | — | — | — |
| Receivables | $37.8M | $38.2M | $36.3M | $22.2M | $24.8M | $17.9M | $7.4M | $6.5M | $3.4M | $2.0M |
| Total current assets | $64.7M | $54.0M | $54.3M | $98.6M | $115.1M | $32.9M | $27.1M | $15.7M | $8.8M | $10.2M |
| Property, plant and equipment | $106.0K | $150.0K | $149.0K | $137.4K | $143.8K | $148.9K | $176.0K | $149.3K | $167.3K | $173.6K |
| Goodwill | $70.9M | $70.9M | $78.4M | $22.7M | $14.7M | $14.7M | $14.7M | $3.7M | — | — |
| Other intangibles | $40.8M | $45.5M | $49.4M | $13.0M | $10.6M | $12.1M | $13.9M | $2.8M | $638.8K | $772.4K |
| Total assets | $176.9M | $171.2M | $183.4M | $134.7M | $141.0M | $60.3M | $56.6M | $25.1M | $9.8M | $11.5M |
| Short-term debt | $4.3M | $2.0M | $2.0M | — | — | — | — | — | — | — |
| Total current liabilities | $21.3M | $18.7M | $17.9M | $8.4M | $9.4M | $10.0M | $6.1M | $4.2M | $3.5M | $3.7M |
| Long-term debt | $21.4M | $30.8M | $34.2M | — | — | — | — | — | — | — |
| Total liabilities | $48.6M | $54.2M | $56.8M | $8.5M | $9.6M | $10.4M | $11.8M | $6.6M | $3.5M | — |
| Retained earnings | -$79.2M | -$84.4M | -$64.3M | -$46.7M | -$35.3M | -$35.6M | -$33.4M | -$30.3M | -$30.4M | -$28.3M |
| Total equity | $128.3M | $117.0M | $126.6M | $126.1M | $131.4M | $50.0M | $44.9M | $18.5M | $6.2M | $7.8M |
Cash flow
| Fiscal year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $18.7M | $4.9M | -$7.2M | $10.7M | $726.0K | -$6.3M | -$1.7M | $792.6K | -$1.5M | -$466.0K |
| Depreciation and amortisation | $102.0K | $111.0K | $100.0K | $2.0M | $2.0M | $95.2K | $80.2K | $58.4K | $48.6K | $22.4K |
| Stock-based compensation | $7.0M | $11.5M | $13.7M | $15.7M | $5.5M | $3.2M | $2.3M | $2.5M | $87.4K | $175.2K |
| Capital expenditure | $58.0K | $112.0K | $87.0K | $81.0K | $100.3K | $68.0K | $87.7K | $34.4K | $42.2K | $178.4K |
| Investing cash flow | $68.0K | -$450.0K | -$25.3M | -$58.2M | -$486.0K | -$124.7K | -$10.6M | -$5.7M | -$42.2K | -$349.5K |
| Financing cash flow | -$8.8M | -$4.9M | $28.2M | -$19.0M | $73.9M | -$1.9M | $22.2M | $8.7M | -$390.0K | -$357.4K |
| Buybacks | — | — | $7.5M | $20.0M | — | — | — | — | $390.0K | $806.9K |
Figures as tagged in each year's own filing, in US dollars. A year restated by a later filing shows the restated figure. Capital expenditure, dividends and buybacks are cash out, shown positive. A line the filer does not report is not listed. Latest from accession 0001213900-26-049698.
Plot the figures US dollars
- Revenue
- Gross profit
- Net income
| Fiscal year | FY2016 | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $7.8M | $12.1M | $21.2M | $24.6M | $43.3M | $4.5M | $62.5M | $71.5M | $92.1M | $109.4M |
| Gross profit | $4.3M | $6.0M | $12.2M | $15.4M | $24.1M | $35.6M | $39.0M | $42.9M | $59.4M | $73.6M |
| Net income | -$1.5M | -$2.1M | $226.3K | -$3.1M | -$2.2M | $378.1K | -$11.4M | -$17.6M | -$20.1M | $5.1M |
Recent filings and events
- Results announced The quarterly or annual earnings release. Arrives four times a year from almost every company here. Item 2.02
- Officer or director change Someone at the top arrived or left. The item covers everything from a board retirement to a chief executive being removed, and only the filing itself says which. Item 5.02
- Regulation FD disclosure Something the company told the market and had to tell everyone at once - usually a slide deck or a press release. Item 7.01
- Officer or director change Item 5.02
- Shareholder vote The results of the annual meeting or a special vote. Item 5.07
- Officer or director change Item 5.02
- Material agreement signed The company entered an agreement outside the ordinary course of business - a large contract, a credit facility, a merger agreement. Item 1.01
- Material agreement terminated An agreement that mattered has ended. Often the other half of a deal that fell through. Item 1.02
- Results announced Item 2.02
- New debt or obligation The company has taken on debt or a comparable obligation. Item 2.03
- Officer or director change Item 5.02
- Regulation FD disclosure Item 7.01
Item numbers are Form 8-K's own, and a filing date is up to four business days after the thing it reports. The same feed across the whole market.
Others in SIC 7389
| Ticker | Company | Market cap | P/E | Revenue growth |
|---|---|---|---|---|
| MA | Mastercard Inc | $550.02B | 37.7x | 16.4% |
| ACN | Accenture plc | $152.67B | 20.5x | 7.4% |
| UBER | Uber Technologies, Inc | $136.24B | 14.1x | 18.3% |
| MELI | MERCADOLIBRE INC | $91.77B | 45.9x | 34.3% |
| DASH | DoorDash, Inc. | $77.93B | 84.2x | 27.9% |
| EBAY | EBAY INC | $54.03B | 28.0x | 7.9% |
| PYPL | PayPal Holdings, Inc. | $50.30B | 10.5x | 4.3% |
| MSCI | MSCI Inc. | $44.76B | 39.2x | 9.7% |